Table 1 Utility values used in the base-case analysis
From: Competing treatments for migraine: a headache for decision-makers
Health states | Mean | SE |
|---|---|---|
0–3 MHD on-treatment | 0.7573 | 0.1662 |
4–9 MHD on-treatment | 0.6449 | 0.2817 |
10–14 MHD on-treatment | 0.6764 | 0.2458 |
15–19 MHD on-treatment | 0.6420 | 0.2543 |
20–23 MHD on-treatment | 0.5916 | 0.2549 |
24–28 MHD on-treatment | 0.5040 | 0.2835 |
0–3 MHD off-treatment | 0.7573 | 0.1662 |
4–9 MHD off-treatment | 0.6449 | 0.2817 |
10–14 MHD off-treatment | 0.6764 | 0.2458 |
15–19 MHD off-treatment | 0.6420 | 0.2543 |
20–23 MHD off-treatment | 0.5916 | 0.2549 |
24–28 MHD off-treatment | 0.5040 | 0.2835 |